Adverse Drug Reaction (ADR) In the pre-approval clinical experience with a new medicinal product or its new usages, particularly as the therapeutic dose(s) may not be established, all noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions. The phrase responses to...
The Atlantic Clinical Trials Network (ACTN) will receive approximately $2.5 million for the creation of various student training opportunities at the masters, PhD, postdoctoral and postdoctoral fellow levels, along with the creation of six new positions in Atlantic Canada focused...
By Chris Stover The medications people take, and the guidelines doctors follow are built on evidence gathered through clinical trials. For more than 25 years, Dr. Thomas Ransom has contributed to that evidence as an endocrinologist and clinical trial investigator...
A critical part of cancer care is clinical trials. In fact, over the past four decades, all advances in cancer treatments have only been possible because of this important part of research. Located at the QEII Health Sciences Centre’s Victoria...
By: Kirsten Millar People who have been affected by cancer, whether as a patient, caregiver, friend, or loved one, know how important it is to have the best possible tools to help fight back. At Nova Scotia Health, the Atlantic...
Nova Scotia Health's ACCRU becomes first site in Canada to open the Novartis Adjuvant WIDER global clinical trial evaluating whether a medication called ribociclib can lower the risk of early-stage breast cancer returning.
By: Allison Currie Cape Breton has reached a global milestone, providing local patients with access to cutting-edge cardiology care through clinical research. This achievement further cements Nova Scotia’s growing reputation as a leader in healthcare innovation. A research team in...
By: Kirsten Millar Our small East Coast province is putting itself on the map once again with a new, groundbreaking advance in cancer care. The QEII Health Sciences Centre in Halifax has become the first global site for a new...
When cancer is rare, aggressive, and difficult to treat, standard therapies can be limited. Patients and clinicians grappling with this reality are left asking: what else might help? Two new clinical trials now open in Nova Scotia are trying to...
Using innovation and research to solve health challenges and transform care for Nova Scotians 2020 – The Strategic Partnership Office and Innovation Launchpad was established. An Innovation Team was deployed as part of Nova Scotia’s COVID-19 Response Strategy. 2021 – The Innovation Catalyst Fund was formed, VirtualCareNS was launched after...